4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0000950170-24-073289
Chief Operating Officer sold 40,000 shares at an average $33.36 ($1,334,201)
- Chief Operating Officer acquired 40,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| HIGH SUSANNA GATTI Chief Operating Officer | 2024-06-12 | Option exercise 10b5-1 | +40,000 | $5.54 | $221,600 | 188,792 | D |
| HIGH SUSANNA GATTI Chief Operating Officer | 2024-06-12 | Sale 10b5-1 | −26,036 | $33.17 | $863,614 | 162,756 | D |
| HIGH SUSANNA GATTI Chief Operating Officer | 2024-06-12 | Sale 10b5-1 | −13,964 | $33.70 | $470,587 | 148,792 | D |
| Derivatives | |||||||
| HIGH SUSANNA GATTI Chief Operating Officer | 2024-06-12 | Option exercise · Stock option (right to buy) 10b5-1 | −40,000 | 100,486 | D | ||
| Open-market sales · 40,000 sh · avg $33.36 · $1,334,201 | |||||||
Loading xslF345X05/ownership.xml…